Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Microbot Medical ( (MBOT) ) has issued an update.
On June 30, 2025, Microbot Medical Inc. announced its inclusion in the Russell Microcap® Index, effective immediately. This milestone reflects the company’s strong execution and momentum, particularly as it prepares for the anticipated Q3 launch of its LIBERTY Endovascular Robotic System, pending FDA clearance. The inclusion enhances Microbot Medical’s visibility at a crucial time, potentially impacting its operational and commercial strategies positively.
The most recent analyst rating on (MBOT) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Microbot Medical stock, see the MBOT Stock Forecast page.
More about Microbot Medical
Microbot Medical Inc. is a pre-commercial stage medical technology company focused on redefining endovascular robotics. It has developed the world’s first single-use, fully disposable endovascular robotic system, aiming to improve the quality of care for patients and providers globally.
Average Trading Volume: 2,606,517
Technical Sentiment Signal: Buy
Current Market Cap: $90.94M
Learn more about MBOT stock on TipRanks’ Stock Analysis page.